Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00217854 · ClinicalTrials.gov registry record · NA

Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT00217854 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00217854, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

The purpose of this study is to examine inflammatory processes in the airway of moderate to severe persistent asthmatics who have persistent bronchial hyperreactivity despite chronic administration of inhaled glucocorticoids.

Interventions

  • PROCEDURE Bronchoscopic

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2001-09
Est. Completion 2011-02
Phase NA

What the Registry Record Tells You About NCT00217854

The ClinicalTrials.gov registry entry for NCT00217854 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Bronchoscopic is the first listed.

NCT00217854 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00217854 about?

NCT00217854 is a clinical study titled "Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity". The purpose of this study is to examine inflammatory processes in the airway of moderate to severe persistent asthmatics who have persistent bronchial hyperreactivity despite chronic administration of inhaled glucocorticoids.

What is the current status of trial NCT00217854?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2001-09. Estimated completion is 2011-02.

What interventions are being tested in trial NCT00217854?

The interventions under investigation include: Bronchoscopic (PROCEDURE).

Who is sponsoring clinical trial NCT00217854?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.